General MedicationsTOPICALGeneric
VIRAC REX
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
Standard Dose
0.5%;1.8%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview VIRAC REX is listed in Drugs@FDA under application 011914 (NDA).
Marketing status: Discontinued Active ingredient LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX Form and strength SOLUTION;TOPICAL - 0.5%;1.8% Sponsor CHESEBROUGH PONDS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview VIRAC REX is listed in Drugs@FDA under application 011914 (NDA). Marketing status: Discontinued Active ingredient LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX Form and strength SOLUTION;TOPICAL - 0.5%;1.8% Sponsor CHESEBROUGH PONDS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.